AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Go back to AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC| Amgen Inc (NASDAQ: AMGN) | Delayed: 362.12 +1.57 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $360.55 | 52 Week High | $176.85 | |||
| Open | $362.15 | 52 Week Low | $133.64 | |||
| Day High | $362.78 | P/E | 54.54 | |||
| Day Low | $356.87 | EPS | $6.64 | |||
| Volume | 2,246,783 | |||||

